Masimo Gains FDA Clearance for Continuous Oxygen Delivery Monitoring
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
Irvine, California, USA, August 7, 2026 Tarsus Pharmaceuticals has announced a definitive agreement to acquire Alkeus Pharmaceuticals, a privately...
Amsterdam, Netherlands, August 7, 2026 Royal Philips has expanded its open patient monitoring ecosystem through a series of strategic...
Irvine, Calif., July 27, 2026 Masimo, a Danaher company and global leader in patient monitoring technologies, has received U.S....
CLEVELAND, Ohio and HOUSTON, Texas, June 5, 2026 Neuronoff has achieved a major clinical milestone with the successful implantation...
WHITE PLAINS, New York, June 5, 2026 Retia Medical has announced a significant expansion of its commercial partnership with...
SUNNYVALE, Calif., May 13, 2026 Cepheid, a Danaher company, announced that it has received CE marking under the European...
NEW YORK, May 13, 2026 Pfizer has received European Commission approval for HYMPAVZI® (marstacimab) for the treatment of adults...
JERSEY CITY, N.J. and OR YEHUDA, Israel, May 11, 2026 Exero Medical has announced positive pivotal clinical study results...
WARSAW, Ind., December 16, 2025 — Zimmer Biomet Holdings, Inc., a global leader in medical technology, has entered into...
